RIPK3 and cancer: As necroptosis is a new cell death pathway distinct from apoptosis, necroptosis inducer may bypass the apoptosis-resistant blockade in killing cancer cells,15,16 along with which the agents manipulating RIP3 expression will open the therapeutic possibility to make them sensitive to necroptosis.